Hepatitis B Foundation

Analysis

Hepatitis B Foundation is a registered charity in United States, based in Doylestown, PA. It received its IRS tax-exemption ruling in March 1992, 34 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Hepatitis B Foundation reported income of $3.0m and spending of $2.8m, spending 95% of its income. Across the 5 years on record, from June 2019 to June 2023, income grew from $1.9m to $3.0m (+54%), an average of +11% a year. The sharpest change came in the year to June 2021, when income rose by 39%. Over the whole period it spent 85% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Hepatitis B Foundation sits at the 75th percentile: it is larger than about 75% of them. Against every charity in United States with reported income it ranks in the 89th percentile, and in the 87th percentile within PA. Charities of a similar size with the same main cause include Jewish Omni Services Inc ($3.0m), Metro Drug Coalition Inc ($3.0m) and Florida Breast Cancer Coalition Research Foundation ($3.0m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 73% and program service revenue 24% of the total. Compensation of current officers, directors and key employees was $227k (8.0% of expenses). Other salaries and wages came to $1.0m. At year end it held assets of $20.2m against liabilities of $1.5m, net assets of $18.7m. It reported 21 employees.